After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Ionis Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Ionis Pharmaceuticals Inc is $9.77B. A total of 1.79 million shares were traded on the day, compared to an average of 2.45M shares.
In the most recent transaction, O’NEIL PATRICK R. sold 1,700 shares of IONS for 64.58 per share on Sep 12 ’25. After the transaction, the EVP CLO & General Counsel now owns 57,130 company shares. In a previous transaction on Sep 09 ’25, Baroldi Joseph sold 11,950 shares at 62.16 per share. IONS shares that EVP, Chief Business Officer owns now total 31,926.
Among the insiders who sold shares, O’NEIL PATRICK R. disposed of 21,000 shares on Sep 09 ’25 at a per-share price of $64.56. This resulted in the EVP CLO & General Counsel holding 57,130 shares of IONS after the transaction. In another insider transaction, Baroldi Joseph sold 250 shares at $62.00 per share on Sep 05 ’25. Company shares held by the EVP, Chief Business Officer now total 31,926.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, IONS has a high of $64.71 and a low of $23.95.
As of this writing, IONS has an earnings estimate of -$1.04 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.72 per share and a lower estimate of -$1.33. The company reported an EPS of -$0.72 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IONS’s latest balance sheet shows that the firm has $2.11B in Cash & Short Term Investments as of fiscal 2021. There were $1.25B in debt and $240.55M in liabilities at the time. Its Book Value Per Share was $3.97, while its Total Shareholder’s Equity was $771.74M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
